---
title: Enhancing the Therapeutic Properties of a Cancer-Targeting Affibody by Soft Mutagenesis
description: "Download this app note to discover how Combinatorial Variant Libraries can be used to:\n\nUndertake Soft mutagenesis to optimize the properties of a dimeric VEGFR2 binding affibody\nPrecisely tune mutants-per-clone for effective soft mutagenesis\nOptimize other proteins, including enzymes and pharmacologically relevant binding proteins\nIncrease the speed of each design-build-test cycle"
image: https://go.technologynetworks.com/hubfs/Technology%20Networks/Landing%20Pages/Twist%20Bio/September%202021/Untitled-2.png
---

![BlueTwoLine](https://go.technologynetworks.com/hubfs/Technology%20Networks/Logos/BlueTwoLine.png "BlueTwoLine")

![BlueTwoLine](https://go.technologynetworks.com/hubfs/Technology%20Networks/Logos/BlueTwoLine.png "BlueTwoLine")

![TN_Stacked_White-1](https://go.technologynetworks.com/hubfs/Imported%20images/TN_Stacked_White-1.png "TN_Stacked_White-1")

App Note 

# Enhancing the Therapeutic Properties of a Cancer-Targeting Affibody by Soft Mutagenesis

Affibodies are synthetic antigen-binding proteins. They offer many advantages over monoclonal antibodies, including smaller sizes, enhanced thermal stability and rapid refolding capability. These advantages make affibodies an attractive platform for the development of therapeutics, diagnostics and bioimaging technology. The same high throughput screening methods to engineer and optimize antibodies can be applied to the engineering of affibodies.

**Download this app note to discover how Combinatorial Variant Libraries can be used to:**

- Undertake Soft mutagenesis to optimize the  
  properties of a dimeric VEGFR2 binding affibody
- Precisely tune mutants-per-clone for effective soft mutagenesis
- Optimize other proteins, including enzymes and pharmacologically relevant binding proteins
- Increase the speed of each design-build-test cycle

**Brought to you by:**

 

**![twist-full-logo-transparent-250x130_copy](https://go.technologynetworks.com/hs-fs/hubfs/DDN/DDN%20Webinar%20Images/TWIST%20Biopharma%20July%209/twist-full-logo-transparent-250x130_copy.png?width=182&name=twist-full-logo-transparent-250x130_copy.png)**

 

**Download this app note to discover how Combinatorial Variant Libraries can be used to:**

- Undertake Soft mutagenesis to optimize the properties of a dimeric VEGFR2 binding affibody
- Precisely tune mutants-per-clone for effective soft mutagenesis
- Optimize other proteins, including enzymes and pharmacologically relevant binding proteins
- Increase the speed of each design-build-test cycle

Access this App Note for FREE Now!

![TN_Stacked](https://go.technologynetworks.com/hubfs/Imported%20images/TN_Stacked.svg "TN_Stacked")

Technology Networks Limited   
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK   
Email: privacy@technologynetworks.com   
© 2021 Technology Networks. All rights reserved

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our [Privacy Policy](https://www.technologynetworks.com/tn/privacy)

This content is copyright protected. Any public or private use of this content is subject to prevailing copyright laws. Please contact [Technology Networks](https://www.technologynetworks.com/tn/copyright) for permission requests.